Intangible assets as of September 30, 2024 consist of the following (in thousands):


	Gross Amount		Accumulated Amortization and Impairment		Net Carrying Value		Weighted Average Remaining Useful Life (Years)
503B pharmacy license	$	28,596	$	(238)	$	28,358	9.9
Trade name	24,170		(8,662)		15,508		6.7
Other	4,831		(3,879)		952		6.1
Intangible assets, net	$	57,597	$	(12,779)	$	44,818	8.7

Intangible assets as of December 31, 2023 consist of the following (in thousands):


	Gross Amount		Accumulated Amortization and Impairment		Net Carrying Value		Weighted Average Remaining Useful Life (Years)
Trade name	$	24,170	$	(6,880)	$	17,290	7.4
Other	4,803		(3,519)		1,284		5.7
Intangible assets, net	$	28,973	$	(10,399)	$	18,574	7.3

Amortization expense for intangible assets was $0.9 million and $0.8 million for the three months ended September 30, 2024 and 2023, respectively, and $2.4 million and $2.8 million for the nine months ended September 30, 2024 and 2023, respectively.

There were no impairment charges on intangible assets for the three and nine months ended September 30, 2024 and 2023.

Amortization that will be charged to expense over the remaining life of the intangible assets subsequent to September 30, 2024 is as follows (in thousands):


The remainder of 2024	$	1,379
2025	5,485
2026	5,339
2027	5,213
2028	5,213
2029 and thereafter	22,189
	$	44,818